Chlamydia and gonorrhoea point-of-care testing in Australia: Where should it be used?

Lisa Natoli, Rebecca J. Guy, Mark Shephard, Basil Donovan, Christopher K. Fairley, James Ward, David G. Regan, Belinda Hengel, Lisa Maher

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Background Diagnoses of chlamydia and gonorrhoea have increased steadily in Australia over the past decade. Testing and treatment is central to prevention and control but in some settings treatment may be delayed. Testing at the point of care has the potential to reduce these delays. We explored the potential utility of newly available accurate point-of-care tests in various clinical settings in Australia. Methods: In-depth qualitative interviews were conducted with a purposively selected group of 18 key informants with sexual health, primary care, remote Aboriginal health and laboratory expertise. Results: Participants reported that point-of-care testing would have greatest benefit in remote Aboriginal communities where prevalence of sexually transmissible infections is high and treatment delays are common. Some suggested that point-of-care testing could be useful in juvenile justice services where young Aboriginal people are over-represented and detention periods may be brief. Other suggested settings included outreach (where populations may be homeless, mobile or hard to access, such as sex workers in the unregulated sex industry and services that see gay, bisexual and other men who have sex with men). Point-of-care testing could also improve the consumer experience and facilitate increased testing for sexually transmissible infections among people with HIV infection between routine HIV-management visits. Some participants disagreed with the idea of introducing point-of-care testing to urban services with easy access to pathology facilities. Conclusions: Participants felt that point-of-care testing may enhance pathology service delivery in priority populations and in particular service settings. Further research is needed to assess test performance, cost, acceptability and impact.

LanguageEnglish
Pages51-58
Number of pages8
JournalSexual Health
Volume12
Issue number1
DOIs
Publication statusPublished - 1 Jan 2015

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Cite this

Natoli, L., Guy, R. J., Shephard, M., Donovan, B., Fairley, C. K., Ward, J., ... Maher, L. (2015). Chlamydia and gonorrhoea point-of-care testing in Australia: Where should it be used? Sexual Health, 12(1), 51-58. https://doi.org/10.1071/SH14213
Natoli, Lisa ; Guy, Rebecca J. ; Shephard, Mark ; Donovan, Basil ; Fairley, Christopher K. ; Ward, James ; Regan, David G. ; Hengel, Belinda ; Maher, Lisa. / Chlamydia and gonorrhoea point-of-care testing in Australia : Where should it be used?. In: Sexual Health. 2015 ; Vol. 12, No. 1. pp. 51-58.
@article{886de822a28d42a79afa212996cb5705,
title = "Chlamydia and gonorrhoea point-of-care testing in Australia: Where should it be used?",
abstract = "Background Diagnoses of chlamydia and gonorrhoea have increased steadily in Australia over the past decade. Testing and treatment is central to prevention and control but in some settings treatment may be delayed. Testing at the point of care has the potential to reduce these delays. We explored the potential utility of newly available accurate point-of-care tests in various clinical settings in Australia. Methods: In-depth qualitative interviews were conducted with a purposively selected group of 18 key informants with sexual health, primary care, remote Aboriginal health and laboratory expertise. Results: Participants reported that point-of-care testing would have greatest benefit in remote Aboriginal communities where prevalence of sexually transmissible infections is high and treatment delays are common. Some suggested that point-of-care testing could be useful in juvenile justice services where young Aboriginal people are over-represented and detention periods may be brief. Other suggested settings included outreach (where populations may be homeless, mobile or hard to access, such as sex workers in the unregulated sex industry and services that see gay, bisexual and other men who have sex with men). Point-of-care testing could also improve the consumer experience and facilitate increased testing for sexually transmissible infections among people with HIV infection between routine HIV-management visits. Some participants disagreed with the idea of introducing point-of-care testing to urban services with easy access to pathology facilities. Conclusions: Participants felt that point-of-care testing may enhance pathology service delivery in priority populations and in particular service settings. Further research is needed to assess test performance, cost, acceptability and impact.",
author = "Lisa Natoli and Guy, {Rebecca J.} and Mark Shephard and Basil Donovan and Fairley, {Christopher K.} and James Ward and Regan, {David G.} and Belinda Hengel and Lisa Maher",
year = "2015",
month = "1",
day = "1",
doi = "10.1071/SH14213",
language = "English",
volume = "12",
pages = "51--58",
journal = "Sexual Health",
issn = "1448-5028",
publisher = "CSIRO",
number = "1",

}

Natoli, L, Guy, RJ, Shephard, M, Donovan, B, Fairley, CK, Ward, J, Regan, DG, Hengel, B & Maher, L 2015, 'Chlamydia and gonorrhoea point-of-care testing in Australia: Where should it be used?', Sexual Health, vol. 12, no. 1, pp. 51-58. https://doi.org/10.1071/SH14213

Chlamydia and gonorrhoea point-of-care testing in Australia : Where should it be used? / Natoli, Lisa; Guy, Rebecca J.; Shephard, Mark; Donovan, Basil; Fairley, Christopher K.; Ward, James; Regan, David G.; Hengel, Belinda; Maher, Lisa.

In: Sexual Health, Vol. 12, No. 1, 01.01.2015, p. 51-58.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Chlamydia and gonorrhoea point-of-care testing in Australia

T2 - Sexual Health

AU - Natoli, Lisa

AU - Guy, Rebecca J.

AU - Shephard, Mark

AU - Donovan, Basil

AU - Fairley, Christopher K.

AU - Ward, James

AU - Regan, David G.

AU - Hengel, Belinda

AU - Maher, Lisa

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Background Diagnoses of chlamydia and gonorrhoea have increased steadily in Australia over the past decade. Testing and treatment is central to prevention and control but in some settings treatment may be delayed. Testing at the point of care has the potential to reduce these delays. We explored the potential utility of newly available accurate point-of-care tests in various clinical settings in Australia. Methods: In-depth qualitative interviews were conducted with a purposively selected group of 18 key informants with sexual health, primary care, remote Aboriginal health and laboratory expertise. Results: Participants reported that point-of-care testing would have greatest benefit in remote Aboriginal communities where prevalence of sexually transmissible infections is high and treatment delays are common. Some suggested that point-of-care testing could be useful in juvenile justice services where young Aboriginal people are over-represented and detention periods may be brief. Other suggested settings included outreach (where populations may be homeless, mobile or hard to access, such as sex workers in the unregulated sex industry and services that see gay, bisexual and other men who have sex with men). Point-of-care testing could also improve the consumer experience and facilitate increased testing for sexually transmissible infections among people with HIV infection between routine HIV-management visits. Some participants disagreed with the idea of introducing point-of-care testing to urban services with easy access to pathology facilities. Conclusions: Participants felt that point-of-care testing may enhance pathology service delivery in priority populations and in particular service settings. Further research is needed to assess test performance, cost, acceptability and impact.

AB - Background Diagnoses of chlamydia and gonorrhoea have increased steadily in Australia over the past decade. Testing and treatment is central to prevention and control but in some settings treatment may be delayed. Testing at the point of care has the potential to reduce these delays. We explored the potential utility of newly available accurate point-of-care tests in various clinical settings in Australia. Methods: In-depth qualitative interviews were conducted with a purposively selected group of 18 key informants with sexual health, primary care, remote Aboriginal health and laboratory expertise. Results: Participants reported that point-of-care testing would have greatest benefit in remote Aboriginal communities where prevalence of sexually transmissible infections is high and treatment delays are common. Some suggested that point-of-care testing could be useful in juvenile justice services where young Aboriginal people are over-represented and detention periods may be brief. Other suggested settings included outreach (where populations may be homeless, mobile or hard to access, such as sex workers in the unregulated sex industry and services that see gay, bisexual and other men who have sex with men). Point-of-care testing could also improve the consumer experience and facilitate increased testing for sexually transmissible infections among people with HIV infection between routine HIV-management visits. Some participants disagreed with the idea of introducing point-of-care testing to urban services with easy access to pathology facilities. Conclusions: Participants felt that point-of-care testing may enhance pathology service delivery in priority populations and in particular service settings. Further research is needed to assess test performance, cost, acceptability and impact.

UR - http://www.scopus.com/inward/record.url?scp=84924487865&partnerID=8YFLogxK

U2 - 10.1071/SH14213

DO - 10.1071/SH14213

M3 - Article

VL - 12

SP - 51

EP - 58

JO - Sexual Health

JF - Sexual Health

SN - 1448-5028

IS - 1

ER -